MarketCap
Facebook
X
TelegramQuartalsbericht 2026-Q1
hinzugefügt 06.05.2026
MannKind Corporation Langfristiger Schuldenstrom 2011-2026 | MNKD
Langfristiger Schuldenstrom Jährlich MannKind Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.11 M | 2.42 M | 1.42 M | 1.3 M | 1.38 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.42 M | 1.3 M | 1.73 M |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
103 K | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
102 K | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
181 K | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | China |
 |
AstraZeneca PLC
AZN
|
382 M | - | - | $ 96.9 B |  Britain |
 |
Athira Pharma
ATHA
|
465 K | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
773 K | - | 0.74 % | $ 768 M |  Israel |
 |
Galera Therapeutics
GRTX
|
133 K | - | -32.59 % | $ 7.61 M | USA |
 |
Esperion Therapeutics
ESPR
|
2.1 M | $ 3.13 | - | $ 651 M | USA |
 |
Eton Pharmaceuticals
ETON
|
65 K | $ 34.45 | 4.74 % | $ 927 M | USA |
|
Forte Biosciences
FBRX
|
416 K | $ 20.31 | 1.2 % | $ 263 M | USA |
 |
Grifols, S.A.
GRFS
|
117 M | $ 8.19 | 4.46 % | $ 5.57 B |  Spain |
 |
Celyad Oncology SA
CYAD
|
137 K | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
3.29 M | - | -7.31 % | $ 87 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
4.21 M | $ 6.82 | 1.94 % | $ 187 M | Israel |
 |
Generation Bio Co.
GBIO
|
13 M | - | - | $ 344 M | USA |
 |
IMV
IMV
|
320 K | - | - | $ 13.1 M | Canada |
 |
BioNTech SE
BNTX
|
45 M | $ 90.36 | 2.93 % | $ 21.8 B | Germany |
 |
Autolus Therapeutics plc
AUTL
|
4.56 M | $ 1.62 | -0.61 % | $ 431 M | Britain |
 |
Ayala Pharmaceuticals
AYLA
|
419 K | - | - | $ 7.46 M | Israel |
 |
Compugen Ltd.
CGEN
|
521 K | $ 2.71 | -0.92 % | $ 253 M | Israel |
 |
Anika Therapeutics
ANIK
|
2.05 M | $ 15.14 | 2.16 % | $ 217 M | USA |
 |
Advaxis
ADXS
|
166 K | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
215 K | - | 5.93 % | $ 314 M | Canada |
 |
Incyte Corporation
INCY
|
5.7 M | $ 97.08 | 1.55 % | $ 19 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
3.47 M | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
56 K | $ 3.39 | 4.17 % | $ 5.58 M | Israel |
 |
AIkido Pharma
AIKI
|
554 K | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
193 K | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
337 K | - | -39.0 % | $ 4.57 M | USA |
 |
Coherus BioSciences
CHRS
|
1.83 M | $ 1.51 | 2.03 % | $ 177 M | USA |
 |
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
3.08 M | - | -0.23 % | $ 916 M | USA |
 |
AlloVir
ALVR
|
316 K | - | 4.14 % | $ 49.1 M | USA |
 |
Allakos
ALLK
|
4.16 M | - | - | $ 28.6 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
294 K | $ 20.47 | 4.97 % | $ 2.6 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
317 K | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
274 K | - | -11.43 % | $ 502 K | USA |